The authors present an important set of data implicating ETFDH as an epigenetically suppressed gene in cancer with tumor suppressive functions. The evidence is solid, with the authors demonstrating ...

The study, which used flow cytometry rather than molecular biology to identify circulating tumor cells (CTCs), found a ...

After treatment with CAR-T cells—immune cells engineered to attack cancer—patients sometimes tell their doctors they feel ...

Study in mice found transient microglial depletion, or chemokine receptor blockade, resolved immunotherapy-related cognitive impairment.

To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows ... variability in cell population frequencies ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments ...

The time-weighted rate of return calculates the compounded growth rate of a portfolio over time. The time-weighted rate of return (TWR) measures a portfolio's compound growth rate while excluding ...

These FAQs are in addition and subject to the Launch a Memory T&Cs. If any contradiction exists between the contents of these FAQs and the contents of the Launch a Memory T&Cs, then the contents of ...

Flow cytometry was performed to analyse peripheral blood B-cells, PCs and Siglec-1 expression on monocytes as surrogate marker for type-I interferon (IFN) activity. Results Upon proteasome inhibition, ...